Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21262163 | 0.88 | CYP1A2 (0.52) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL28865583 | 0.88 | L3MBTL1 (0.42) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL1674842 | 0.88 | CYP1A2 (0.52) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL27750312 | 0.86 | KMT2A (0.50) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL27278231 | 0.86 | L3MBTL1 (0.47) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL9714798 | 0.85 | ZDHHC7 (0.51) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL9489696 | 0.85 | ZDHHC7 (0.51) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL240521 | 0.84 | ZDHHC7 (0.47) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL36999 | 0.84 | ZDHHC7 (0.47) | L3MBTL1KMT2APOLBALDH1A1TRPA1 | |
| SCHEMBL20321136 | 0.84 | L3MBTL1 (0.46) | L3MBTL1KMT2APOLBALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270235-A1 | COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED OF A DIASTEREOISOMERICALLY ENRICHED PCTA AND SYNTHESIS METHOD | GUERBET SA (FR) | 2025-08-28 | — | — | US | disclosed |
| CN-119552163-A | Complexes of gadolinium and chelating ligands based on diastereoisomerically enriched PCTA and methods of making and purifying same | 法国加栢 | 2025-03-04 | — | — | CN | disclosed |
| CN-113698400-B | Diastereoisomeric enriched complexes of gadolinium and PCTA-based chelating ligands and methods of synthesis | 法国加栢 | 2025-01-28 | — | — | CN | disclosed |
| CN-113646308-B | Complexes of gadolinium and chelating ligands based on diastereoisomerically enriched PCTA and methods of making and purifying same | 法国加栢 | 2024-12-13 | — | — | CN | disclosed |
| CN-113646309-B | Diastereoisomeric enriched complexes of gadolinium and PCTA-based chelating ligands and methods of synthesis | 法国加栢 | 2024-11-22 | — | — | CN | disclosed |
| CN-118791488-B | Compounds, chelates and their use in magnetic resonance imaging | 成都施贝康生物医药科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20240358863-A1 | COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED FROM A DIASTEREOISOMERICALLY ENRICHED PCTA AND PREPARATION AND PURIFICATION PROCESS | GUERBET SA (FR) | 2024-10-31 | — | — | US | disclosed |
| CN-118791488-A | Compounds, chelates and their use in magnetic resonance imaging | 成都施贝康生物医药科技有限公司 | 2024-10-18 | — | — | CN | disclosed |
| US-12064487-B2 | Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process | GUERBET (FR) | 2024-08-20 | — | — | US | disclosed |
| US-12036289-B2 | Gadolinium bearing PCTA-based contrast agents | BRACCO IMAGING S.P.A. (IT) | 2024-07-16 | — | — | US | disclosed |
| US-5034418-A | Anticoagulants | EISAI CO., LTD. (JP) | 1991-07-23 | — | — | US | disclosed |
| US-4978767-A | ANTICOAGULANTS | EISAI CO., LTD. (JP) | 1990-12-18 | — | — | US | disclosed |
| US-4954523-A | ANTICOAGULANT | EISAI CO., LTD. (JP) | 1990-09-04 | — | — | US | disclosed |
| US-4920131-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4918081-A | Quinoline derivatives and use thereof as antagonists of leukotriene d4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-17 | — | — | US | disclosed |
| WO-1989012628-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-12-28 | — | — | WO | disclosed |
| WO-1989012629-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-12-28 | — | — | WO | disclosed |
| EP-0348155-A1 | Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1989-12-27 | — | — | EP | disclosed |
| US-4886834-A | ANTICOAGULANTS | EISAI CO., LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| EP-0238973-A2 | Diphenyl-methane derivative, pharmaceutical composition and use | Eisai Co., Ltd. (JP) | 1987-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270235-A1 | COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED OF A DIASTEREOISOMERICALLY ENRICHED PCTA AND SYNTHESIS METHOD | CCKBR, SCLY, GRPR | L3MBTL1 4202/4885KMT2A 2183/4885POLB 2737/4885 |
| US-20240358863-A1 | COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED FROM A DIASTEREOISOMERICALLY ENRICHED PCTA AND PREPARATION AND PURIFICATION PROCESS | TSHR, QRFPR, SCTR | L3MBTL1 4325/4885KMT2A 2441/4885POLB 3094/4885 |
| US-12064487-B2 | Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process | TSHR, QRFPR, SCTR | L3MBTL1 4325/4885KMT2A 2441/4885POLB 3094/4885 |
| US-12036289-B2 | Gadolinium bearing PCTA-based contrast agents | GLRX3, GLRA1, GRHPR | L3MBTL1 2820/4885KMT2A 2230/4885POLB 3869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.